LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p

Table 1 Correlation between DLX6-AS1 expression and clinicopathological parameters of patients with ovarian cancer

Clinical feature	n	DLX6-AS1		P value
Clinical feature	n	High	Low	P value
Age (years)				0.3943
≥ 50	27	12	15
< 50	23	13	10
CA-125 (U/mL)				0.5688
≥ 500	28	13	15
< 500	22	12	10
Histological grade				0.0209
G1-2	30	11	19
G3	20	14	6
FIGO				0.0087
III + IV	19	14	5
I + II	31	11	20
Lymph node metastasis				0.0055
Negative	35	13	22
Positive	15	12	3

ISSN: 1475-2867